Trial Details

UNKNOWN
Basic Information
Clinical ID c2488
Identifier NCT03422861
Trial Title Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Nabilone|DRUG: Placebos
Participant Information
Sponsor Samuel Lunenfeld Research Institute, Mount Sinai Hospital
City Ontario
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2023-12
Primary Completion Date 2024-09
Completion Date 2024-12